There were 1,409 press releases posted in the last 24 hours and 428,143 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image